Rev M10 gene therapy
Latest Information Update: 07 Mar 2017
At a glance
- Originator University of Michigan
- Class Antivirals; Gene therapies
- Mechanism of Action Rev gene product inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 07 Mar 2017 Discontinued - Phase-II for HIV infections in USA (IV)
- 20 Jul 2000 No-Development-Reported for HIV infections in USA (IV)
- 22 Jun 2000 Warner-Lambert has merged with Pfizer